Pharma News, 2015

October 22, 2015 -- The U.

Ballerup, Denmark 19 October, 2015.

After a long and expensive clinical journey, Relypsa ($RLYP) won FDA approval to commercialize patiromer--to be sold as Veltassa--for hyperkalemia.

The following database contains a listing of drugs approved by the Food and Drug Administration (FDA) for sale in the United States.

​Immunotherapy is touted more and more as the future of cancer treatment.

The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, and Australia will rise in value from $1.

This morning 23andMe announced that it’s back, once again offering direct-to-consumer genetic tests from which consumers will draw health conclusions.

Nimbus Therapeutics, a biotechnology company focused on harnessing the power of computational chemistry to design breakthroughs for serious, underserved diseases, today announced an exclusive worldwid...

BEIJING--(BUSINESS WIRE)--Yabao Pharmaceutical Co.

First FDA approval of a specific reversal agent for a novel oral anticoagulant (NOAC)1    Praxbind® immediately reverses the anticoagulant action of dabigatran 2,3Ingelhei...

The most influential source for U.

The European Commission (EC) has approved Basilea Pharmaceutica's isavuconazole (Cresemba) product to treat invasive aspergillosis and mucormycosis.